AFRI NASDAQ Week ended 24 Jul 2026

Weekly Investor Report

Forafric Global PLC Ordinary Shares · Consumer Defensive · Farm Products

Open interactive chart View report data Download investor PDF
Latest close 10.51 USD
-3.1% latest week
Weekly setup

Constructive, but selective

The weekly trend is active. Price is 4.5% above the Trend Line and sits at 77.0% of its 52-week range. The latest completed week returned -3.1%, after a 3.0% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 50/100. Near-term considerations: volume confirmation is below normal; earnings are due in 22d.

Setup score 54 out of 100
Latest Close 10.51 USD 24 Jul 2026
1W Return -3.1% latest completed week
4W Return 3.0% short-term follow-through
12W Return 3.0% quarterly tape
Trend Breadth 51.9% 27 of 52 weeks active
Volume Ratio 0.6x vs 13-week average
What is working
  • The trend backdrop is active with a 2-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • No major top-level risk cluster is currently dominant.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -3.1% Latest completed week; four-week move 3.0%. Indicator stack 35/79 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. News sentiment 50/100 32 relevant articles in the latest sentiment read. Event risk 22d Next report is scheduled for 21 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 4.5% above the Trend Line and sits at 77.0% of its 52-week range. The latest completed week returned -3.1%, after a 3.0% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.6x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
30 Jan 6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.5212-week average 0.51

12-week confirmation

Trend active2/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership1/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.52Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 3.0% over four weeks, 3.0% over 12 weeks, and 34.9% over one year. The current trend has remained active for 2 consecutive weeks.

Performance by holding period

1W-3.1%
4W3.0%
12W3.0%
26W4.7%
52W34.9%
Active trend streak2 weeks
Active weeks in one year27
Trend breadth51.9%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.83Latest activity-pressure read.
Pressure change172.5%Four-week change in activity pressure.
Leadership-0.39Latest relative-leadership reading.
RS change93.4%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Dec 2025 Field coverage 76% Model confidence 73%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength80/100Blend of value, momentum, and quality. Underlying universe rank 21; rank 1 is best.
Value65/100Relative valuation strength. Underlying universe rank 36; rank 1 is best.
Quality63/100Profitability and accounting quality. Underlying universe rank 38; rank 1 is best.
Momentum65/100Medium-term price momentum. Underlying universe rank 36; rank 1 is best.
Growth65/100Revenue and earnings growth. Underlying universe rank 36; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
1.6x
Market value relative to trailing revenue.
EV / EBITDA
109.9x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
0.2%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
10.2%
Gross profit retained from each unit of revenue.
Operating margin
-1.4%
Operating profit retained from revenue.
Free-cash-flow margin
0.5%
Free cash flow generated from revenue.
Return on invested capital
-1.4%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
5/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
-3.5%
Net share repurchases relative to market value.
Shareholder yield
-3.5%
Dividend yield plus net buyback yield.
Net debt / EBITDA
35.9x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment50/100

Weighted news tone is neutral across 32 relevant articles.

4 positive · 25 neutral · 3 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings22dNext report is scheduled for 21 Aug 2026; event risk rises as the date approaches.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-8.0%Distance below the 52-week high.
13-week volatility2.3%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher13 of 2613 weeks finished lower.
Best week+7.1%Week of 24 Apr.
Worst week-3.8%Week of 5 Jun.
Latest week-3.1%Week of 24 Jul.

Shape of recent returns

Strong gains2
Modest gains11
Flat weeks0
Modest losses13
Sharp losses0
Recent vol2.3%13-week weekly-return volatility.
Base vol4.0%52-week weekly-return volatility.
Up/down split26/26Count of positive and negative weeks in the 52-week window.
Average skew3.4% / -2.1%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape53/100

Trend, activity pressure, participation, and risk combine to a 53/100 tape read.

 Indicator analysis45/100

Latest 12-week confirmation: trend 2/12, activity pressure 12/12, relative leadership 1/12.

Activity pressure 0.52; No reversal markers Factors68/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 81; Small Cap Core rank 44 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment50/100

Weighted news tone is neutral across 32 relevant articles.

Enterprise value to EBITDA forward of Forafric Global PLC – NASDAQ:AFRI Insiders50/100

No recent insider transaction evidence is stored.

 Earnings22d

Next report is scheduled for 21 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
24 Jul 202610.51 USD-3.1%10.05 USD10.00 USD0.83-0.3964.3KOn
17 Jul 202610.85 USD2.5%10.06 USD10.01 USD0.801.3988.7KOn
10 Jul 202610.59 USD3.6%10.06 USD10.01 USD0.59-4.9646.2KOff
3 Jul 202610.22 USD0.2%10.07 USD10.01 USD0.44-6.5697.8KOff
26 Jun 202610.20 USD1.5%10.08 USD10.02 USD0.30-5.91428.2KOff
19 Jun 202610.05 USD0.5%10.08 USD10.02 USD0.14-11.4451.7KOff
12 Jun 202610.00 USD2.2%10.06 USD10.03 USD0.15-9.6649.4KOff
5 Jun 20269.78 USD-3.8%10.04 USD10.03 USD0.23-9.7063.8KOff
29 May 202610.17 USD3.0%10.03 USD10.04 USD0.33-10.4428.2KOff
22 May 20269.87 USD-1.3%10.00 USD10.05 USD0.42-10.7189.3KOff
15 May 202610.00 USD-1.6%9.98 USD10.05 USD0.54-8.60150.0KOff
8 May 202610.16 USD-0.4%9.94 USD10.05 USD0.18-7.5585.9KOff
1 May 202610.20 USD-1.6%9.88 USD10.06 USD-0.20-2.3098.5KOff
24 Apr 202610.37 USD7.1%9.83 USD10.06 USD-0.560.7189.8KOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.